Andrews Liver Salts Effervescent Powder

*
General Sale: Non-prescription
qrcode image

Scan the QR code or enter an email to access and share this medicine:

Updated on 30 May 2025

File name

MASTER-ie-text-pil-andrews-IE03 MAH-implemented 19May2025.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

The marketing authorisation holder is

Haleon Ireland Limited, Clocherane, Dungarvan, Co. Waterford, Ireland.

Updated on 30 May 2025

File name

MASTER-ie-spc-andrews-IE03 MAH-implemented 19May2025.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

7 MARKETING AUTHORISATION HOLDER

Haleon Ireland Limited

Clocherane,

Youghal Road,

Dungarvan,

Co. Waterford,

X35 Y983,

Ireland.

Updated on 27 June 2023

File name

Master-ie-pil-andrews_-Approved 20June2023.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Free text change information supplied by the pharmaceutical company

Update to section 6 MAH now Haleon Ireland Limited12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Updated on 27 June 2023

File name

MASTER-ie-spc-andrews--appoved 20June2023.pdf

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Update to MAH in Section 7 to Haleon

Update to Revision of text in Section 10

Updated on 09 January 2023

File name

MASTER-ie-spc-andrews-678-043-001-approved-July2015.pdf

Reasons for updating

  • Document format updated

Legal category:Supply through general sale

Updated on 03 May 2016

File name

PIL_9241_862.pdf

Reasons for updating

  • New PIL for new product

Updated on 03 May 2016

Reasons for updating

  • Change to MA holder contact details

Updated on 10 July 2015

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale

Updated on 10 July 2015

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 7

Marketing Authorisation Holder address updated to:

12 Riverwalk,

Citywest Business Campus,

Dublin 24,

Ireland

Updated on 22 May 2015

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.8 - Addition of HPRA reporting statement

Updated on 21 May 2015

Reasons for updating

  • Change to side-effects

Updated on 03 December 2012

Reasons for updating

  • Change due to harmonisation of PIL

Updated on 13 August 2010

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to information about pregnancy or lactation

Updated on 24 August 2009

Reasons for updating

  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.3: Addition of hypersensitivity as a contraindication.
Section 4.4: Addition of warning re sugar intolerances.
Section 4.6: Addition of warnings re pergnancy.

Updated on 20 February 2009

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.3
the following text is added:
 

This product should not be given to patients with a hypersensitivity to any component of Andrews Liver Salts or any previous hypersensitivity to Andrews Liver Salts.

 
Section 4.4
the following text is added:
 

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

Updated on 28 August 2007

Reasons for updating

  • Improved electronic presentation

Updated on 30 May 2007

Reasons for updating

  • Improved electronic presentation

Updated on 22 May 2007

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

6.5 Nature and Contents of Container

Removal of reference to 'integral 5 ml spoon'

Updated on 20 April 2007

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

1. Name of the medicinal product

Change name to: Andrews Liver Salts Effervescent Powder

6.4 Special Precautions for Storage

Amend wording as follows: Keep the container tightly closed.

6.5 Nature and Contents of Container

Include statement: Not all pack sizes may be marketed.

10. Date of revision of text

April 2007

Updated on 18 November 2004

Reasons for updating

  • New PIL for medicines.ie

Updated on 20 August 2003

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through general sale

Updated on 19 August 2003

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through general sale

Updated on 12 August 2003

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through general sale

Updated on 25 June 2003

Reasons for updating

  • New SPC for medicines.ie

Legal category:Supply through general sale

Haleon Ireland Limited

  • Address:

    12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
  • Medical Information Direct Line:

    1800 441 442